Adenosine Inhibits Excitatory but Not Inhibitory Synaptic Transmission in the Hippocampus
Adenosine may affect CNS function by inhibiting synaptic release of neurotransmitters (Dunwiddie, 1985; Fredholm and Dunwiddie, 1988) . This may be explained by at least two separate physiological effects of adenosine. First, adenosine increases a potassium conductance that is modulated by a G-protein Jackson, 1985, 1987) . Second, voltagegated calcium currents in peripheral neurons are directly blocked by adenosine (Dolphin et al., 1986; Macdonald et al., 1986) . At a nerve terminal, either mechanism could reduce calcium entry and subsequent transmitter release. It is not clear whether adenosine also antagonizes calcium currents in central neurons (Gerber et al., 1989; Scholz et al., 1989) . Despite gaps in our knowledge about adenosine's biophysical effects on transmitter release, there is firm biochemical and physiological evidence that it limits the release of some transmitters in the CNS. For example, adenosine reduces potassium-stimulated release of glutamate and aspartate in hippocampal slices and also blocks excitatory synaptic responses in hippocampal slices and cultures (Schubert and Mitzdorf, 1979; Burke and Nadler, 1988; Fredholm et al., 1989; Scholz et al., 1989) . Information about adenosine effects on GABA release is conflicting. While some investigators suggest that adenosine reduces GABA output (Hollins and Stone, 
Materials and Methods
We used dissociated l-d-postnatal rat hippocampal cell cultures 5-12 d in vitro for all experiments. Details of culture methods have been described elsewhere (Yamada et al., 1989) . The tight-seal, whole-cell recording technique (Hamill et al., 1981) was used to voltage clamp postsynaptic cells and intracellularly stimulate presynaptic cells. The culture medium was exchanged with extracellular fluid containing (in mM) NaCl(140), KC1 (3), Na HEPES (lo), glucose (5.5), CaCl, (4), and MgCl, (4), with pH adjusted to 7.3. The electrodes were fabricated by pulling glass capillaries (1.2-mm outer diameter) in two steps. Series resistance was usually 10-l 5 MQ. The intracellular solution contained (in mM) K isethionaie (138), KC1 (2), Na HEPES (lo), EGTA (1. l), ducose (4). and ATP-Ma, (2). With these solutions. inhibitorv oostsvnaptic cu%nts (IPSCs) reve&d at -70 mV, and excitatory postsynaptic currents (EPSCs) at above 0 mV (Fig. 1) . All pipette solutions were adjusted to pH 7.2, and experiments were done at room temperature. Currents and voltage signals were digitized at 1 KHz for off-line analysis.
We obtained synaptic pairs by simultaneously recording from two nearby neurons within a microscope field. None of the presynaptic cells required current injection to maintain a stable resting membrane potential and action potential that peaked above 0 mV. A depolarizing current of 5-msec duration was injected through a balanced bridge into the presynaptic cell to initiate an action potential. A pair of cells was considered monosynaptically connected if an action potential in one cell always elicited a postsynaptic current in the second cell and if there was less than a 5-msec delay between presynaptic action potential peak and onset of postsynaptic current. Some drugs were added to extracellular fluid by whole-bath perfusion. The fluid in the culture dish (about 0.5 ml) was exchanged manually with syringe and continuous vacuum suction. To assess effects of drugs, five consecutive synaptic currents (5 set apart) were averaged and compared in the absence and presence of drug. After return of control solution, any synaptic pair showing a decline in current greater than 25% of control was deleted from analysis. In some experiments, drugs were applied directly onto the cell bodies by glass capillary tubes with l-2-pm tip diameters. After filling the capillaries with desired solutions, they were connected to an air pressure source (10 psi) and gated by a square-wave pulse of lO-20-msec duration. The tip of capillary was placed at the position where the maximum current was elicited, usually 5-l 0 pm from the cell surface. The drug responses are expressed as percent of the current peaks obtained in the normal extracellular fluid. The numerical data are expressed as mean + standard error, and significance was tested by two-tailed or paired t tests according to the appropriateness of comparison. All drugs were obtained from Sigma (St. Louis) except for (+)-baclofen, which was a gift from Ciba Geigy.
Results
All monosynaptic EPSCs were attenuated by adensosine (1 O-100 PM; Figs. 2, 3). On average, the peak EPSC declined to 2 1.9 f 4.2% (mean f SEM; n = 7; p < 0.001) of control at 100 PM. Surprisingly, adenosine, even at this high concentration, had no significant effect on the IPSCs (Fig. 2B ). On average, the peak IPSC during bath application of adenosine was 90.8 + 7.1% of control (n = 9; p > 0.1). In separate experiments using a lower adenosine concentration, we examined the effect of the adenosine antagonist theophylline. Adenosine at 10 PM reduced EPSCs to 23.1 + 5.0% of control, and this effect was largely reversed by coapplication of theophylline (500 I.IM in all experiments) to 96.9 * 4.6% (n = 3; p < 0.001; Fig. 3 ). Theophylline therefore attenuates the adenosine block of EPSCs, suggesting that specific adenosine receptors, likely of the A, subtype, mediate this block (Fredholm and Dunwiddie, 1988) . At a higher adenosine concentration (50 PM), attenuation of the adenosine effect by theophylline (500 PM) was limited to 38.1 + 4.3% of control compared to 19.6 + 4.0%, consistent with the low potency of theophylline (Fig. 3B ). Of note, there was no significant difference in adenosine effect between 10 and 100 PM, indicating that the response has saturated by 10 PM (Fig. 2C9 .
In an attempt to determine the mechanism of adenosine action, we measured the effect of adenosine on the resting potentials of inhibitory and excitatory neurons during the synaptic pair experiments. The average resting membrane potential of the excitatory cells was -82 + 4 mV before and -85 + 4 mV (n = 12) during bath application of adenosine (p > 0.2, paired t test). The average resting membrane potentials of the inhibitory neurons changed from -72 k 3 mV to -70 f 3 mV (n = 9) with adenosine (p > 0.1, paired t test). Thus, adenosine is not merely hyperpolarizing excitatory neurons. Even at this high concentration of adenosine, no other significant postsynaptic effects were observed. The average chord resistance of neurons receiving excitatory synaptic inputs changed from 232.9 f 90.8 MQ to 241.5 + 100.5 MO (range, -5.3% to + 10.0% change with adenosine). The postsynaptic cells receiving inhibitory connections also had insignificant chord resistance changes from 236.8 f 36.5MQto228.1 + 33.3MQ(range, -24.7%to +27.6O/b change with adenosine). No significant correlation between changes in chord resistance and the adenosine reduction of synaptic currents was seen in either group (Fig. 4AJ) . While the insignificant effects of adenosine on passive neuronal properties combined with the marked differences in attenuation of excitatory and inhibitory currents argue strongly against a postsynaptic site of action of adenosine, we were concerned that our findings could still be an artifact of faulty space clamping of distal synapses. This could come about if excitatory synapses were located at sites electrotonically distant from the cell body while inhibitory synapses were on the cell soma. Two additional observations make this extremely unlikely. First, when EPSCs inhibited by adenosine were scaled to the same size as controls, their time courses superimposed almost exactly (Fig.  5A,B) . If adenosine altered the cable properties of postsynaptic neurons, this would not be expected. Second, when glutamate, the likely excitatory neurotransmitter in our cultures (Rothman and Samaie, 1985; Yamada et al., 1989) , was directly applied to neurons at concentrations between 30 and 300 PM, the currents were not diminished by adenosine (Fig. 5C) .
These experiments indicate that adenosine selectively diminishes EPSCs but not IPSCs, likely by differentially inhibiting the release of excitatory neurotransmitter. Adenosine can still diminish polysynaptic IPSCs, which are indirectly triggered by an initial EPSC on an inhibitory interneuron. We found two examples of such a situation in our paired recordings where an evoked monosynaptic EPSC was followed by a likely disynaptic IPSC (Figs. 1, 6 ). Both were reduced by adenosine. This could be a mechanism for limiting GABA release in vivo where feedforward and feedback inhibition are triggered by excitatory synapses.
In order to determine whether the adenosine observations would generalize to other presynaptic receptors, we studied the effect of baclofen (SO-100 PM; racemic mixture) on inhibitory and excitatory pairs. Baclofen significantly reduced the synaptic currents of both excitatory and inhibitory connections (Fig. 7) . EPSCs were reduced to 21.9 + 2.4% (n = 6) of control, and IPSCs were reduced to 29.1 +_ 5.3% (n = 5) of control at 100 PM and 29.2 f 7.5% (n = 5) of control at 50 FM, confirming a number of other reports that baclofen blocks transmitter release (Westbrook and Pun, 1983; Harrison, 1990) . We observed small changes in the passive membrane properties of the postsynaptic or presynaptic cells with baclofen, but these cannot account for the decreases in synaptic currents. were reduced in amplitude without any shift in the reversal potential (Fig. 8) . In excitatory neurons, the average resting membrane potentials were -78 f 3 mV before and -78 + 3 mV during baclofen (n = 9). In inhibitory neurons, the average resting membrane potentials were -6 3 f 5 mV before and -6 1 f 6 mV during baclofen (n = 6; p > 0.2). Of interest, the resting potentials of inhibitory neurons averaged over all groups were more depolarized (-67 + 3 mV, n = 2 1) than those of the excitatory neurons (-80 f 2 mV, n = 27; p < 0.001).
Discussion
Our observations confirm that adenosine can attenuate synaptic activity. In our cultures this effect is restricted to excitatory, glutamatergic neurons (Rothman and Samaie, 1985; Yamada et al., 1989) and is clearly distinct from presynaptic inhibition by baclofen. In addition, our results provide further support for the hypothesis that excitatory and inhibitory neurons are physiologically very different. The precise mechanism of adenosine action has not been determined by our experiments. However, the evidence is very compelling that the site of action of both adenosine and baclofen is presynaptic in our cultures. First, in the cultured neurons, neither adenosine nor baclofen had a very large influence on passive membrane properties. Although a G-protein-coupled potassium channel has been identified in cells similar to ours Jackson, 1985, 1987; Nicoll, 1988) , it is inconsistently expressed in culture such that responses may vary among platings or be absent altogether (L. 0. Trussell, personal com- munication). Likewise, the effect of baclofen on these channels, which is robust in the hippocampal slice (Andrade et al., 1986 ) is small or not even detectable in culture (Harrison, 1990) . Second, a variety of physiological and neurochemical experiments (Fredholm and Dunwiddie, 1988; Harrison, 1990) have consistently shown that these compounds have the capability of reducing transmitter release via a presynaptic action. Third, adenosine in our experiments had no effect on the currents elicited by direct postsynaptic glutamate application. Fourth, adenosine did not influence the time course of EPSCs, which would be expected if it modified postsynaptic cable properties. Fifth, baclofen had no effect on the IPSC reversal potential. We were not able to reverse EPSCs with either adenosine or baclofen under conditions that allowed us to maintain synaptic transmission.
Finally, Scholz and Miller (199 1) have recently demonstrated that adenosine diminishes voltage-gated calcium currents in cultured hippocampal pyramidal neurons, but not in cultured hippocampal neurons, which stain for glutamate decarboxylase and are presumably inhibitory interneurons. This result correlates with our observations and suggests that adenosine could diminish excitatory transmitter release by blocking calcium currents in synaptic terminals. However, other possible mechanisms for synaptic modulation by adenosine, such as increase in potassium conductance Jackson, 1985, 1987) , cannot be excluded at this time.
We have considered the possibility that adenosine could inhibit inhibitory transmission at sufficiently high concentrations, but we do not believe that this is very realistic. Because 10 PM adenosine maximally inhibited EPSCs, the failure to diminish 2 3 boclofen 100 j& wash
IPSCs with 100 PM suggests a true difference between excitatory and inhibitory neurons. The clear-cut separation of adenosine and baclofen effects is intriguing, as others have suggested that their postsynaptic effects (increase in potassium conductance) are mediated by the same second-messenger systems (Nicoll, 1988) . We cannot tell if our inhibitory neurons lack adenosine receptors at their terminals or only the coupling mechanism between receptors and ion channels.
While at least three previous reports have indicated that passive and active membrane characteristics of excitatory and inhibitory neurons differ (Schwartzkroin and Mathers, 1978; McCormick et al., 1985; Huettner and Bat&man, 1988) , there is only one well-documented example of such a qualitative difference in drug sensitivity between functionally distinct classes of central neurons. In that case, hippocampal inhibitory interneurons, but not pyramidal neurons, were hyperpolarized by enkephalin (Madison and Nicoll, 1988) . Interestingly, this suggests that opiates and adenosine may have functionally opposite roles in the hippocampus. Opiates can selectively excite pyramidal neurons in the hippocampus through their inhibition of inhibitory intemeurons (Zieglgansberger et al., 1979) while adenosine dampens pyramidal excitability.
Regardless of the explanation for adenosine's selective reduction of excitatory transmission, the finding has potential therapeutic implications for problems such as epilepsy. Drugs related to adenosine that selectively block the release of excitatory transmitter, but fail to alter tonic release of inhibitory transmitter, might reduce seizure discharges more effectively than agents that nonspecifically diminish all transmitter release.
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